To add to the opacity surrounding LAG-3 expression on tumour cells, a recent abstract (American Society of Clinical Oncology Meeting 2020) reported expression of LAG-3 on tumour cells from B cell lymphomas as well as a range of epithelial tumours including lung, breast, and ovarian cancers [116]. This evidence concerns the gene LAG3 and ovarian carcinoma.